Published in Cell Immunol on October 15, 1989
Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2007) 1.49
Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. J Immunol (2009) 1.48
Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology (1990) 1.15
Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients. Proc Natl Acad Sci U S A (1993) 0.95
Spontaneous development of autoimmune uveoretinitis in nude mice following reconstitution with embryonic rat thymus. Clin Exp Immunol (1991) 0.87
Contrasting immunopathogenic properties of highly homologous peptides from rat and human thyroglobulin. Immunology (1997) 0.86
The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU). Cytokine (2015) 0.76
Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Mol Vis (2011) 0.76
Uveitogenic epitopes of retinal S-antigen are generated in vivo via an alternative antigen-presentation pathway. Immunology (1998) 0.75
Analysis of the uveitogenic determinant in repeat structure of retinal interphotoreceptor retinoid-binding protein (IRBP). Clin Exp Immunol (1994) 0.75
Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea. Anal Biochem (1986) 4.83
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (1987) 3.85
A cellular basis for genetically controlled immunologic unresponsiveness in mice: tolerance induction in T-cells. Proc Natl Acad Sci U S A (1973) 2.52
Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol (1977) 2.48
Genetic control of immune response to glutamic acid, alanine, tyrosine copolymers in mice. I. Association of responsiveness to H-2 genotype and specificity of the response. J Immunol (1972) 2.29
A dominant Stargardt's macular dystrophy locus maps to chromosome 13q34. Arch Ophthalmol (1994) 1.59
Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields. Eye (Lond) (1996) 1.54
Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. J Immunol (2001) 1.54
A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family. Invest Ophthalmol Vis Sci (2001) 1.48
Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol (1993) 1.47
Space-occupying orbital masses in children. A review of 250 consecutive biopsies. Ophthalmology (1986) 1.43
Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology (1982) 1.38
Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci (1995) 1.37
Management of posterior uveal melanoma. Surv Ophthalmol (1992) 1.29
Polypeptide variants of beta-arrestin and arrestin3. J Biol Chem (1993) 1.27
Primary and secondary structure of bovine retinal S antigen (48-kDa protein). Proc Natl Acad Sci U S A (1987) 1.25
Growth rates and doubling times of posterior uveal melanomas. Ophthalmology (1984) 1.20
Role of the major histocompatibility gene products in regulating the antibody response to dinitrophenylated poly(L-Glu55,L-Ala35,L-Phe9)n. J Exp Med (1980) 1.16
Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol (2001) 1.16
A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Invest Ophthalmol Vis Sci (1997) 1.11
S-antigen-specific rat T cell lines recognize peptide fragments of S-antigen and mediate experimental autoimmune uveoretinitis and pinealitis. J Immunol (1986) 1.11
Congenital retinal macrovessels. Arch Ophthalmol (1982) 1.05
Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology (1982) 1.05
Ocular anomalies simulating double optic discs. Can J Ophthalmol (1981) 1.03
S-antigen immunoreactivity in human pineal glands and pineal parenchymal tumors. A monoclonal antibody study. Acta Neuropathol (1986) 1.01
Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. J Immunol (1990) 1.00
Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis. J Immunol (1989) 1.00
Mucosa specific lymphocytes in the human conjunctiva, corneoscleral limbus and lacrimal gland. Curr Eye Res (1994) 0.99
Retinal S-antigen and retinoblastoma: a monoclonal antibody and flow cytometric study. Invest Ophthalmol Vis Sci (1985) 0.98
S-antigen in the developing retina and pineal gland: a monoclonal antibody study. Invest Ophthalmol Vis Sci (1985) 0.97
The ocular surface as part of the mucosal immune system: conjunctival mucosa-specific lymphocytes in ocular surface pathology. Eye (Lond) (1995) 0.97
Rhodopsin and retinoblastoma. A monoclonal antibody histopathologic study. Arch Ophthalmol (1986) 0.96
S-antigen: characterization of a pathogenic epitope which mediates experimental autoimmune uveitis and pinealitis in Lewis rats. Curr Eye Res (1987) 0.95
Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental?. Arch Ophthalmol (1996) 0.95
Neuroblastic differentiation potential of the human retinoblastoma cell lines Y-79 and WERI-Rb1 maintained in an organ culture system. An immunohistochemical, electron microscopic, and biochemical study. Am J Pathol (1989) 0.94
Choroidal neovascularization in an eye with a macular hole. Ann Ophthalmol (1989) 0.94
Fresh-frozen cucumber as a mount for conjunctival and corneal tissue in cryomicrotomy. Arch Ophthalmol (1994) 0.93
Scatter photocoagulation for choroidovitreal neovascularization. Retina (1984) 0.93
Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes. J Immunol (1991) 0.93
Flow cytometry of uveal melanomas. Cancer Biochem Biophys (1986) 0.93
Retinal S antigen and retinoblastoma. A monoclonal antibody histopathologic study. Arch Ophthalmol (1985) 0.93
DNA-binding activity of retinoblastoma protein is intrinsic to its carboxyl-terminal region. Cell Growth Differ (1990) 0.92
Metastatic uveal melanoma: diffuse hepatic metastasis in a patient with concurrent normal serum liver enzyme levels and liver scan. Arch Ophthalmol (1985) 0.92
Malattia leventinese presenting with subretinal neovascular membrane and hemorrhage. Am J Ophthalmol (2001) 0.92
Epitope mapping of bovine retinal S-antigen with monoclonal antibodies. Curr Eye Res (1988) 0.90
Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats. Cell Immunol (1990) 0.90
Adaptive changes in visual cell transduction protein levels: effect of light. Exp Eye Res (1991) 0.90
Immunohistochemical characterization of human retinoblastomas in situ with multiple markers. Am J Ophthalmol (1987) 0.90
Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides. Autoimmunity (1992) 0.90
Characteristics of two new retinoblastoma cell lines: WERI-Rb24 and WERI-Rb27. J Pediatr Ophthalmol Strabismus (1990) 0.89
Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol (1985) 0.89
Histocompatibility-2 system of wild mice. IV. Ia and Ir typing of two wild mouse populations. Cold Spring Harb Symp Quant Biol (1977) 0.89
Cytogenetic findings in primary uveal melanoma. Cancer Genet Cytogenet (1994) 0.89
S-antigen: identification of the MAbA9-C6 monoclonal antibody binding site and the uveitopathogenic sites. Curr Eye Res (1986) 0.89
Effect of hydroxylamine on the subcellular distribution of arrestin (S-antigen) in rod photoreceptors. Vis Neurosci (1994) 0.89
Differential expression of mRNA and protein encoding retinal and pineal S-antigen during the light/dark cycle. J Neurochem (1990) 0.89
Changing concepts in the management of retinoblastoma. Ophthalmic Surg (1990) 0.88
Sequence homology between yeast histone H3 and uveitopathogenic site of S-antigen: lymphocyte cross-reaction and adoptive transfer of the disease. Cell Immunol (1989) 0.88
An 18-mer peptide derived from the retinal S antigen induces uveitis and pinealitis in primates. Clin Exp Immunol (1989) 0.88
Rod cell-specific antigens in retinoblastoma. Arch Ophthalmol (1989) 0.88
Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells. Cell Immunol (1992) 0.88
Genetic control of immune response against random copolymers of glutamic acid and alanine (GA) and tyrosine (GT) in inbred mice. J Immunol (1976) 0.87
Accuracy of clinical estimates of tumor dimensions. A clinical-pathologic correlation study of posterior uveal melanomas. Retina (1985) 0.87
Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14. Am J Ophthalmol (1999) 0.86
Genetic aspects of uveal melanoma: a brief review. Semin Oncol (1996) 0.86
Modification of standard proteinase K/phenol method for DNA isolation to improve yield and purity from frozen blood. J Med Genet (1995) 0.86
An antimelanoma monoclonal antibody and the histopathology of uveal melanomas. Arch Ophthalmol (1985) 0.86
In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen. J Immunol (1991) 0.85
Transient, cyclic changes in mouse visual cell gene products during the light-dark cycle. J Neurosci Res (1992) 0.85
Retinoblastoma-like phenotype expressed in medulloblastomas. J Neuropathol Exp Neurol (1995) 0.85
Identification of a uveitopathogenic and lymphocyte proliferation site in bovine S-antigen. Cell Immunol (1988) 0.85
Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducin. Curr Eye Res (1992) 0.84
Gene complementation in the T lymphocyte proliferative response to poly (Glu57Lys38Tyr5): evidence for effects of polymer handling and gene dosage. J Immunol (1979) 0.84
Conserved T cell receptor V gene usage by uveitogenic T cells. Clin Immunol Immunopathol (1991) 0.84
Human retinal S-antigen. Isolation, purification, and characterization. Invest Ophthalmol Vis Sci (1984) 0.83
Human S-antigen: characterization of uveitopathogenic sites. Curr Eye Res (1988) 0.83
Characterization of human type II procollagen and collagen-specific antibodies and their application to the study of human type II collagen processing and ultrastructure. Matrix Biol (1997) 0.83
Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. Eur J Cancer (1991) 0.83
Human IRBP: characterization of uveitopathogenic sites. Curr Eye Res (1988) 0.83
S-antigen. Experimental autoimmune uveitis following immunization with a small synthetic peptide. Arch Ophthalmol (1987) 0.83
Recent advances in the molecular genetics of retinitis pigmentosa. Curr Opin Ophthalmol (1995) 0.83
Surface and cytoplasmic antigens in retinoblastoma. Invest Ophthalmol Vis Sci (1980) 0.83
Ex vivo transduction of corneal epithelial progenitor cells using a retroviral vector. Invest Ophthalmol Vis Sci (1999) 0.83
The immune response of allophenic mice to the synthetic polymer L-glutamic acid, L-lysine, L-phenylalanine. II. Lack of gene complementation in two nonresponder strains. J Exp Med (1977) 0.83
Glycosidases of Aspergillus niger. 3. Purification and characterization of 1,2- -mannosidase. J Biol Chem (1972) 0.83
Conjunctival instillation of retinal antigens induces tolerance Does it invoke mucosal tolerance mediated via conjunctiva associated lymphoid tissues (CALT)? Ocul Immunol Inflamm (1994) 0.82
Visual results following cobalt plaque radiotherapy for posterior uveal melanomas. Ophthalmology (1984) 0.82